Literature DB >> 22012539

What does it mean?; looking beyond group differences in clinical research.

David Coghill.   

Abstract

Mesh:

Year:  2011        PMID: 22012539     DOI: 10.1007/s00787-011-0222-0

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


× No keyword cloud information.
  6 in total

1.  Clinical significance: a statistical approach to defining meaningful change in psychotherapy research.

Authors:  N S Jacobson; P Truax
Journal:  J Consult Clin Psychol       Date:  1991-02

Review 2.  Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD.

Authors:  Russell A Barkley
Journal:  Psychol Bull       Date:  1997-01       Impact factor: 17.737

Review 3.  Causal heterogeneity in attention-deficit/hyperactivity disorder: do we need neuropsychologically impaired subtypes?

Authors:  Joel T Nigg; Erik G Willcutt; Alysa E Doyle; Edmund J S Sonuga-Barke
Journal:  Biol Psychiatry       Date:  2005-06-01       Impact factor: 13.382

4.  Beyond the dual pathway model: evidence for the dissociation of timing, inhibitory, and delay-related impairments in attention-deficit/hyperactivity disorder.

Authors:  Edmund Sonuga-Barke; Paraskevi Bitsakou; Margaret Thompson
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-04       Impact factor: 8.829

Review 5.  Cardiovascular effects of atomoxetine in children, adolescents, and adults.

Authors:  Joachim F Wernicke; Douglas Faries; Donald Girod; Jeffrey Brown; Haitao Gao; Douglas Kelsey; Humberto Quintana; Robert Lipetz; David Michelson; John Heiligenstein
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

6.  The neuropsychological effects of chronic methylphenidate on drug-naive boys with attention-deficit/hyperactivity disorder.

Authors:  David R Coghill; Sinead M Rhodes; Keith Matthews
Journal:  Biol Psychiatry       Date:  2007-06-01       Impact factor: 13.382

  6 in total
  1 in total

1.  An observational study of response heterogeneity in children with attention deficit hyperactivity disorder following treatment switch to modified-release methylphenidate.

Authors:  Christopher Hautmann; Aribert Rothenberger; Manfred Döpfner
Journal:  BMC Psychiatry       Date:  2013-09-03       Impact factor: 3.630

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.